Results 101 to 110 of about 754,759 (237)

Risk of Dengue in Travelers: Implications for Dengue Vaccination [PDF]

Current Infectious Disease Reports, 2018
Dengue is found in tropics and subtropics that are considered to be popular travel destinations. We set out to review the burden of dengue on international travelers.GeoSentinel, a global network of travel medicine providers, has seen an increasing trend of dengue in returning travelers over the past decades.
openaire   +2 more sources

Dengue virus infection in a course of typhoid fever

Journal of Education, Health and Sport, 2018
Dengue is a mosquito-borne viral infection caused by dengue virus (DENV) belonging to a group of Flaviviridae. Disease is widely spread in tropical and subtropical regions of Southeast Asia, Africa and the Americas.
Aleksander Ryczkowski, Aleksander Sławiński, Zuzanna Toruń, Anna Orzeł, Halina Piecewicz-Szczęsna   +4 more
doaj   +3 more sources

Opportunities and challenges of mRNA technologies in development of dengue virus vaccine

Frontiers in Immunology
Dengue virus (DENV) is a mosquito-borne virus with a significant human health concern. With 390 million infections annually and 96 million showing clinical symptoms, severe dengue can lead to life-threatening conditions like dengue hemorrhagic fever (DHF)
Xiaoyang Liu
doaj   +1 more source

Dengue vaccine acceptance and willingness to pay

Human Vaccines & Immunotherapeutics, 2017
The introduction of new vaccines is accompanied by a variety of challenges. Among these, very important ones concern the questions whether the public is willing to accept and willing to purchase the vaccine.
Harapan Harapan, Jonny K. Fajar, R. Tedjo Sasmono, Ulrich Kuch   +3 more
doaj   +1 more source

Nanoparticle delivery of a tetravalent E protein subunit vaccine induces balanced, type-specific neutralizing antibodies to each dengue virus serotype. [PDF]

PLoS Neglected Tropical Diseases, 2018
Dengue virus (DENV) is the causative agent of dengue fever and dengue hemorrhagic shock syndrome. Dengue vaccine development is challenging because of the need to induce protection against four antigenically distinct DENV serotypes.
Stefan W Metz, Ashlie Thomas, Alex Brackbill, Yi Xianwen, Michele Stone, Katie Horvath, Michael J Miley, Chris Luft, Joseph M DeSimone, Shaomin Tian, Aravinda M de Silva   +10 more
doaj   +1 more source

Zoonotic anxieties: The cultural politics of Nepal's quest for pandemic preparedness

Medical Anthropology Quarterly, EarlyView.
Abstract Based on fieldwork conducted in Nepal (2022–2024) and by paying attention to how local and transnational notions of epidemiological risk are deployed, this ethnography introduces the concept of “zoonotic anxieties” to make sense of the multi‐species relational ethos that contemporary global health regimes propose.
Max D. López Toledano, Hari Basnet, Anna Durrance‐Bagale, Natasha Howard   +3 more
wiley   +1 more source

Immunogenicity and Efficacy of Flagellin-Envelope Fusion Dengue Vaccines in Mice and Monkeys

Clinical and Vaccine Immunology, 2015
The envelope (E) protein of flaviviruses includes three domains, EI, EII, and EIII, and is the major protective antigen. Because EIII is rich in type-specific and subcomplex-specific neutralizing epitopes and is easy to express, it is particularly ...
Ge Liu, Langzhou Song, David W. C. Beasley, R. Putnak, J. Parent, John Misczak, Hong Li, L. Reiserova, Xiangyu Liu, H. Tian, Wenzhe Liu, D. Labonte, L. Duan, Youngsun Kim, L. Travalent, Devin Wigington, Bruce Weaver, L. Tussey   +17 more
semanticscholar   +1 more source

Challenges of Dengue in Hematological Disease Patients: Descriptive Analysis From the DANGO Registry During the 2023–2024 Outbreak in Argentina

Transplant Infectious Disease, EarlyView.
During the 2023–2024 Argentine dengue outbreak, 33 patients with hematological disease showed high complication rates, frequent hospitalization (64%), severe thrombocytopenia (90%), and 6% dengue‐attributable mortality. Transfusion‐associated cases were documented.
Gustavo Adolfo Méndez, Carla Niveyro, Pedro Andrés Villalba Apestegui, Victoria Isabel Martin, Lucila María Compañy Kec, María Cynthia Tomasino, Mariana del Carmen del Marull, Haydee Ingrid Bernard, Claudia Patricia Lorena Fernández, Flavia Marcela Pelech, Maria Fernanda Tosin, María Fernanda González‐Hobecker, Karen Beatrice Duranona, Angela Daiana Jara, Justus Cornely, Oliver A. Cornely, Jon Salmanton‐García   +16 more
wiley   +1 more source

Points for Consideration for dengue vaccine introduction – recommendations by the Dengue Vaccine Initiative

Expert Review of Vaccines, 2016
Dengue is a public health problem in the tropics and subtropics. There are several vaccine candidates in clinical development. However, there may be gaps in the new vaccine introduction after vaccine licensure before it becomes available in developing countries.
Jacqueline Kyungah, Lim, Yong-Seok, Lee, Annelies, Wilder-Smith, Georges, Thiry, Richard, Mahoney, In-Kyu, Yoon   +5 more
openaire   +2 more sources

Efficient Delivery of Dengue Virus Subunit Vaccines to the Skin by Microprojection Arrays

Vaccines, 2019
Dengue virus is the most important arbovirus impacting global human health, with an estimated 390 million infections annually, and over half the world’s population at risk of infection.
David A. Muller, A. Depelsenaire, A. Shannon, D. Watterson, S. Corrie, Nick S. Owens, Christiana Agyei-Yeboah, Stacey T M Cheung, Jin Zhang, G. Fernando, M. Kendall, P. Young   +11 more
semanticscholar   +1 more source